ClinicalTrials.Veeva

Menu

Lung Scintigraphy for Pulmonary Embolism Diagnosis in COVID-19 Patients. (SCINTI-COVID)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

COVID-19
Pulmonary Embolism

Study type

Observational

Funder types

Other

Identifiers

NCT05353608
SCINTI-COVID (29BRC21.0143)

Details and patient eligibility

About

A frequent complication of COVID-19 disease is pulmonary embolism (PE).

Lung ventilation/perfusion (V/P) scintigraphy is a well-established test for PE diagnosis. The test is interpreted based on the recognition of wedge shaped perfusion mismatched defects. However, the ventilation procedure increases the potential risk of contamination by the aerosol secretion and the expired air.

A variety of strategies have been proposed in the nuclear medicine literature regarding performance of lung ventilation scintigraphy in COVID-19 patients with suspected acute PE. However, there is currently no factual data in this specific population to support recommendations to the nuclear medicine community.

The aim of this study was to assess the role of ventilation imaging when performing lung scintigraphy for suspected PE in COVID-19 patients.

Enrollment

183 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with suspected COVID-19 disease
  • Referred for lung scintigraphy for suspected acute PE

Exclusion criteria

  • Patient under guardianship or curatorship
  • Patient deprived of liberty by an administrative or judicial decision
  • Inability or refuse to give consent

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems